| Pomegranate Juice and Extract Consumption Increases the Resistance to UVB-induced Erythema and Changes the Skin Microbiome in Healthy Women: a Randomized Controlled Trial 2019 · Pom extract (PomX) · Healthy women aged 30–40 years | 1 g | 12 weeks | 25 |
| Effects of pomegranate extract on blood flow and running time to exhaustion 2014 · Pomegranate extract (PE) · Highly active men and women, mean age 22.2 years, without a stated diagnosed condition | 1 g | 1 day | 19 |
| An extract of pomegranate fruit and galangal rhizome increases the numbers of motile sperm: a prospective, randomised, controlled, double-blinded trial 2014 · Active treatment · Healthy adult men aged 18 years or older with semen quality below the standards for commercial sperm-bank application | 1 g | 90 days | 32 |
| Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients 2017 · intervention group · Rheumatoid arthritis patients; age range and sex not specified | 500 mg | 8 weeks | 30 |
| Pomegranate Extract Improves Maximal Performance of Trained Cyclists after an Exhausting Endurance Trial: A Randomised Controlled Trial 2019 · Pomegranate extract (PE) · Amateur endurance-trained male cyclists aged 18–55 years | 750 mg | 15 days | 26 |
| Pomegranate extract (POMx) decreases the atherogenicity of serum and of human monocyte-derived macrophages (HMDM) in simvastatin-treated hypercholesterolemic patients: a double-blinded, placebo-controlled, randomized, prospective pilot study 2014 · simvastatin (20 mg/day) + POMx pill · Hypercholesterolemic patients; age and sex not specified | 1 g | 60 days | 12 |
| Effects of Pomegranate Extract Supplementation on Cardiovascular Risk Factors and Physical Function in Hemodialysis Patients 2015 · pomegranate (POM) group · Hemodialysis patients; age range and sex not reported | 1 g | 26 weeks | — |
| Randomized placebo-controlled study of the memory effects of pomegranate juice in middle-aged and older adults 2020 · pomegranate juice group · Adults aged 50–75 years without dementia | 237 mL | 1 year | 126 |
| Cardioprotective Effects of Pomegranate (Punica granatum) Juice in Patients with Ischemic Heart Disease 2017 · test group · Patients with ischemic heart disease diagnosed with unstable angina or myocardial infarction | 220 mL | 5 days | 50 |
| Pomegranate Juice Consumption Improves Sleep Quality and Melatonin Concentration of Patients With Opioid Use Disorders Under Medication-Assisted Treatment With Methadone and Buprenorphine: A Randomized Controlled Trial 2025 · Experimental group (pomegranate juice) · Patients with opioid use disorders receiving medication-assisted treatment with methadone or buprenorphine | 250 mL | 120 days | 40 |
| Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin 2006 · low dose · Healthy women in their 20s to 40s | 100 mg | 4 weeks | 13 |
| Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin 2006 · high dose · Healthy women in their 20s to 40s | 200 mg | 4 weeks | 13 |
| Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease 2005 · pomegranate juice group · Patients with coronary heart disease and myocardial ischemia; age and sex not specified | 240 mL | 90 days | — |
| Pomegranate seed oil in women with menopausal symptoms: a prospective randomized, placebo-controlled, double-blinded trial 2012 · pomegranate seed oil group · postmenopausal women with menopausal symptoms | 60 mg | 12 weeks | — |
| Fermented pomegranate extracts protect against oxidative stress and aging of skin 2022 · FPE-D drink group · Healthy subjects; age and sex not reported | 50 mL | 8 weeks | — |
| Combination of Chemically Characterized Pomegranate Extract and Hydrophilic Vitamins against Prolonged Fatigue: A Monocentric, Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2023 · Group 2 (food supplement) · Adults aged 18–75 years, either sex, with mild-to-moderate prolonged fatigue | 500 mg | 8 weeks | 29 |
| The Effect of a Citrus and Pomegranate Complex on Physical Fitness and Mental Well-Being in Healthy Elderly: A Randomized Placebo-Controlled Trial 2022 · Citrus and pomegranate complex (CPC) · Healthy adults aged 60–75 years, with BMI 18–28 kg/m² | 200 mg | 4 weeks | 36 |
| Influence of a new botanical combination on quality of life in menopausal Spanish women: Results of a randomized, placebo-controlled pilot study 2021 · Herbal extract · Healthy Spanish women aged 45–55 with menopause onset no more than five years earlier and initial Cervantes Scale score ≥53 | 200 mg | 8 weeks | 17 |
| A Randomized, Placebo-Controlled Trial Evaluating Multi-Species Synbiotic Supplementation for Bloating, Gas, and Abdominal Discomfort 2026 · multi-species synbiotic · Generally healthy adult men and women with self-reported bloating/indigestion for at least 3 months and no reported medical diagnosis of a functional GI disorder | 400 mg | 6 weeks | — |
| Effects of Pomegranate Juice on Cardiovascular Risk Factors in Patients with Metabolic Syndrome: a Double-Blinded, Randomized Crossover Controlled Trial 2017 · pomegranate juice · Adults with metabolic syndrome | 500 mL | 7 days | 30 |
| Effects of pomegranate juice consumption on blood pressure and lipid profile in patients with type 2 diabetes: A single-blind randomized clinical trial 2019 · Treatment group · Adults with type 2 diabetes; age and sex not stated | 200 mL | 6 weeks | 30 |
| Short-Term Consumption of Pomegranate Juice Alleviates Some Metabolic Disturbances in Overweight Patients with Dyslipidemia 2021 · intervention group · Adults aged 40–60 with overweight and dyslipidemia | 300 mL | 2 weeks | — |
| A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer 2013 · low-dose POMx (1-POMx) · Men with prostate cancer and rising PSA after local therapy, without radiographic evidence of metastases | 1 g | 548 days | 46 |
| Effect of Pomegranate Peel Consumption on Liver Enzymes, Lipid Profile, Liver Steatosis, and Hs-CRP in Patients With Non-alcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial 2025 · pomegranate peel group · Patients with non-alcoholic fatty liver disease; age and sex not specified | 1 g | 10 weeks | 23 |
| A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance 2021 · pomegranate fruit extract (PFE) · men with organ-confined, favorable-risk prostate cancer on active surveillance | 1 g | 1 year | 15 |
| Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size 2007 · Two POMx capsules per day (Study 2) · Overweight subjects | 1 g | — | — |
| Effects of pomegranate extract supplementation on inflammation in overweight and obese individuals: A randomized controlled clinical trial 2016 · pomegranate extract group · Overweight and obese adults | 1 g | 30 days | — |
| The effect of synbiotics pomegranate juice on cardiovascular risk factors in PCOS patients: a randomized, triple-blinded, controlled trial 2020 · synbiotic pomegranate juice (SPJ) group · Females with PCOS; age range not reported | 300 mL | 8 weeks | — |
| Effects of Pomegranate Extract on Inflammatory Markers and Cardiometabolic Risk Factors in Adults Aged 55-70 Years: A Randomised Controlled Parallel Trial 2025 · pomegranate extract (PE) group · Adults aged 55–70 years, all genders, normal weight or overweight, without diagnosed chronic diseases | 740 mg | 12 weeks | 43 |
| Effects of Pomegranate Extract on IGF-1 Levels and Telomere Length in Older Adults (55-70 Years): Findings from a Randomised Double-Blinded Controlled Trial 2025 · PE group · Adults aged 55–70 years, without chronic disease, with BMI 18.5–29.9 kg/m² | 740 mg | 12 weeks | 43 |
| Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial 2023 · pomegranate peel group · Adults aged 18–60 with non-alcoholic fatty liver disease, liver fibrosis and steatosis; men and women | 1.5 g | 8 weeks | 39 |
| Gene expression changes in colon tissues from colorectal cancer patients following the intake of an ellagitannin-containing pomegranate extract: a randomized clinical trial 2017 · pomegranate extract group · colorectal cancer patients | 900 mg | 5 weeks | 35 |
| A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy 2013 · POMx · Men with prostate adenocarcinoma scheduled for radical prostatectomy | 2 g | 4 weeks | 33 |
| A prospective, randomized, double-blind, placebo-controlled trial of polyphenols on the outcomes of inflammatory factors and oxidative stress in patients with type 2 diabetes mellitus 2022 · PoPEx group · Adults with type 2 diabetes mellitus | 500 mg | 8 weeks | 30 |
| Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size 2007 · One POMx capsule per day · Overweight individuals with increased waist size | 710 mg | — | — |
| Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size 2007 · Two POMx capsules per day (Study 1) · Overweight individuals with increased waist size | 1.42 g | — | — |
| Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial 2010 · PSO group · Hyperlipidaemic subjects diagnosed according to the National Cholesterol Education Program definition; age and sex not reported | 800 mg | 4 weeks | — |
| Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients 2014 · PE-1 (low punicalagin:EA ratio) · Colorectal cancer patients | 900 mg | 15 days | — |
| Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients 2014 · PE-2 (high punicalagin:EA ratio) · Colorectal cancer patients | 900 mg | 15 days | — |
| Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomized clinical trial 2017 · dose-2 (four pomegranate extract capsules) · Healthy overweight-obese individuals with BMI >27 kg/m² | 640 mg | 3 weeks | — |
| The Endotoxemia Marker Lipopolysaccharide-Binding Protein is Reduced in Overweight-Obese Subjects Consuming Pomegranate Extract by Modulating the Gut Microbiota: A Randomized Clinical Trial 2018 · Pomegranate extract D2 · Overweight-obese adults with mild hyperlipidemia | 656 mg | 3 weeks | — |
| Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice 2010 · pomegranate juice consumers · Patients with BPH or prostate cancer undergoing surgery; age and sex not stated | 200 mL | 3 days | — |
| Pharmacological Therapy Determines the Gut Microbiota Modulation by a Pomegranate Extract Nutraceutical in Metabolic Syndrome: A Randomized Clinical Trial 2021 · pomegranate extract nutraceutical · Poly-medicated patients with metabolic syndrome; age and sex not reported | 320 mg | 30 days | 50 |
| Effect of pomegranate seed oil supplementation on the GLUT-4 gene expression and glycemic control in obese people with type 2 diabetes: A randomized controlled clinical trial 2019 · intervention group · Obese people with type 2 diabetes; age and sex not specified | 3 g | 8 weeks | 26 |
| Pomegranate Juice Increases Sirtuin1 Protein in Peripheral Blood Mononuclear Cell from Patients with Type 2 Diabetes: A Randomized Placebo Controlled Clinical Trial 2018 · PJ group · Patients with type 2 diabetes | 250 mL | 12 weeks | 22 |
| Adjuvant pomegranate juice intake improves the inflammatory status of hospitalized COVID-19 patients: A randomized and placebo-controlled trial 2023 · pomegranate juice (PJ) group · Adults over 18 hospitalized with moderate or severe COVID-19 infection | 500 mL | 2 weeks | 21 |
| Acute and long-term effects of grape and pomegranate juice consumption on vascular reactivity in paediatric metabolic syndrome 2010 · pomegranate juice group · Adolescents aged 12–15 years with metabolic syndrome | 240 mL | 30 days | 15 |
| Effects of Grapefruit and Pomegranate Juices on the Pharmacokinetic Properties of Dapoxetine and Midazolam in Healthy Subjects 2017 · pomegranate juice pretreatment · 12 healthy subjects; age and sex not reported | 250 mL | 3 days | 12 |
| Evidence for a Modulatory Effect of a 12-Week Pomegranate Juice Intervention on the Transcriptional Response in Inflammatory Bowel Disease Patients Reducing Fecal Calprotectin Levels: Findings From a Proof-of-Principle Study 2025 · active supplementation (POMJ) · Adults aged 18–80 with ulcerative colitis or Crohn’s disease in stable clinical remission and fecal calprotectin ≥100 µg/g | 250 mL | 12 weeks | 12 |
| Effects of pomegranate juice in circulating parameters, cytokines, and oxidative stress markers in endurance-based athletes: A randomized controlled trial 2016 · PJD group · Endurance-based athletes; age and sex not reported | 200 mL | 3 weeks | 11 |
| Effects of pomegranate juice in circulating parameters, cytokines, and oxidative stress markers in endurance-based athletes: A randomized controlled trial 2016 · PJ group · Endurance-based athletes; age and sex not reported | 200 mL | 3 weeks | 10 |
| Antibacterial Efficacy of Mouthwash Prepared from Pomegranate, Grape Seed and Guava Extracts against Oral Streptococci: An in Vivo Study 2018 · Pomegranate extract mouthwash · Children aged 8–10 years | 30 mL | 7 days | 10 |
| The impact of supplementation with pomegranate fruit (Punica granatum L.) juice on selected antioxidant parameters and markers of iron metabolism in rowers 2018 · supplemented group · Male rowers aged about 20–21 years, members of the Polish National Team | 50 mL | 8 weeks | 10 |
| Three week dietary intervention using apricots, pomegranate juice or/and fermented sour sobya and impact on biomarkers of antioxidative activity, oxidative stress and erythrocytic glutathione transferase activity among adults 2016 · Pomegranate juice (PGJ) group · Healthy Egyptian adults aged 21–35 years, men and women | 250 g | 3 weeks | 7 |
| Pomegranate juice is potentially better than apple juice in improving antioxidant function in elderly subjects 2008 · pomegranate group · Elderly subjects; sex and age range not reported | 250 mL | 4 weeks | — |
| Effects of pomegranate juice supplementation on pulse wave velocity and blood pressure in healthy young and middle-aged men and women 2012 · pomegranate juice group · Healthy adults aged 30–50 years | 330 mL | 4 weeks | — |
| Effects of pomegranate juice consumption on oxidative stress in patients with type 2 diabetes: a single-blind, randomized clinical trial 2017 · PJ consumption group · Adults aged 40–65 with type 2 diabetes | 200 mL | 6 weeks | — |
| Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomized clinical trial 2017 · dose-1 (one pomegranate extract capsule) · Healthy overweight-obese individuals with BMI >27 kg/m² | 160 mg | 3 weeks | — |
| The effect of synbiotics pomegranate juice on cardiovascular risk factors in PCOS patients: a randomized, triple-blinded, controlled trial 2020 · pomegranate juice (PJ) group · Females with PCOS; age range not reported | 300 mL | 8 weeks | — |
| Efficacy of Pomegranate Seed Powder on Glucose and Lipid Metabolism in Patients with Type 2 Diabetes: A Prospective Randomized Double-Blind Placebo-Controlled Clinical Trial 2021 · pomegranate seed powder group · Patients with type 2 diabetes mellitus; age range and sex not reported | 10 g | 8 weeks | — |
| Pomegranate Juice Supplemented with Inulin Modulates Gut Microbiota and Promotes the Production of Microbiota-Associated Metabolites in Overweight/Obese Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial 2024 · PJ · Overweight/obese individuals with BMI 25–35 kg/m² | 200 mL | 3 weeks | — |
| Effects of pomegranate peel extract and vitamin E on the inflammatory status and endothelial function in hemodialysis patients: a randomized controlled clinical trial 2020 · PPE + Vit E · Hemodialysis patients; age and sex ranges not reported | 450 mg | 8 weeks | 25 |
| Effects of pomegranate peel extract and vitamin E on the inflammatory status and endothelial function in hemodialysis patients: a randomized controlled clinical trial 2020 · PPE · Hemodialysis patients; age and sex ranges not reported | 450 mg | 8 weeks | 25 |
| Multi-Species Synbiotic Supplementation Enhances Gut Microbial Diversity, Increases Urolithin A and Butyrate Production, and Reduces Inflammation in Healthy Adults: A Randomized, Placebo-Controlled Trial 2025 · DS-01 multi-species synbiotic · Healthy adults; age range and sex not specified | 400 mg | 13 weeks | 16 |
| Three week dietary intervention using apricots, pomegranate juice or/and fermented sour sobya and impact on biomarkers of antioxidative activity, oxidative stress and erythrocytic glutathione transferase activity among adults 2016 · Pomegranate juice and fermented sour sobya (PGJ+FS) group · Healthy Egyptian adults aged 21–35 years, men and women | 150 g | 3 weeks | 7 |
| Pomegranate Juice Supplemented with Inulin Modulates Gut Microbiota and Promotes the Production of Microbiota-Associated Metabolites in Overweight/Obese Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial 2024 · PJ supplemented with inulin · Overweight/obese individuals with BMI 25–35 kg/m² | 200 mL | 3 weeks | — |
| A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer--the U.K. NCRN Pomi-T study 2014 · Food supplement group (FSG) · Men aged 53–89 with histologically confirmed prostate cancer, managed with active surveillance or watchful waiting, including men with PSA relapse after radical treatment | 300 mg | 26 weeks | 136 |
| Polyphenol-Related Gut Metabotype Signatures Linked to Quality of Life in Postmenopausal Women: A Randomized, Placebo-Controlled Crossover Trial 2025 · Polyphenol-rich supplement (PPs) · Healthy postmenopausal women aged 45–59 with at least one climacteric symptom | 960 mg | 8 weeks | 78 |
| A Citrus and Pomegranate Complex Reduces Methylglyoxal in Healthy Elderly Subjects: Secondary Analysis of a Double-Blind Randomized Cross-Over Clinical Trial 2023 · Citrus and pomegranate complex treatment · Healthy, non-smoking adults aged 60–75 years | 260 mg | 4 weeks | — |